Krabbe disease: An overview

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Pastores, G M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycosphingolipid; Krabbe disease; Leukodystrophy; Lysosomal storage disease

Indexed keywords

GALACTOSYLCERAMIDASE;

DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; GENETICS; GLOBOID CELL LEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METABOLISM; METHODOLOGY; ONSET AGE; REVIEW;

AGE OF ONSET; DIAGNOSIS, DIFFERENTIAL; GALACTOSYLCERAMIDASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKODYSTROPHY, GLOBOID CELL;

EID: 77649222978     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp47075     Document Type: Conference Paper

References (39)

1. Arvidsson J, Hagberg B, Mansson JE, Svennerholm L. Late onset globoid cell leukodystrophy (Krabbe's disease): Swedish case with 15 years of follow-up. Acta Paediatr. 1995; 84: 218-221.
2. Biswas S, Biesiada H, Williams TD, LeVine SM. Substrate reduction intervention by L-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background. Neurosci Lett. 2003; 347: 33-36. (Pubitemid 36831100)
3. Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis. 2006; 29: 413-420. (Pubitemid 43880644)
4. Callahan JW, Skomorowski MA. Diagnosis of Krabbe disease by use of a natural substrate. Methods Mol Biol. 2006; 347: 321-330.
5. Chabali R, Matre WM, Greene MK. Infant with irritability, feeding problems, and progressive developmental abnormalities presenting repeatedly to a pediatric emergency department. Pediatr Emerg Care. 1997; 13: 123-126. (Pubitemid 27174759)
6. Chang SH, Lin SJ, Lee YY, Yang RC, Yang SL. I-cell disease: report of a case. Kaohsiung J Med Sci. 1996; 12: 295-300.
7. Cox TM. Substrate reduction therapy for lysosomal storage diseases. Acta Paediatr. 2005; 94 (Suppl 447): 69-75.
8. Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S et al. Transplantation of umbilicalcord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005; 352: 2069-2081. (Pubitemid 40664308)
9. Escolar ML, Poe MD, Martin HR, Kurtzberg J. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Pediatrics. 2006; 118: e879-e889. (Pubitemid 46090017)
10. Formichi P, Radi E, Battisti C, Pasqui A, Pompella G, Lazzerini PE et al. Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. J Cell Physiol. 2007; 212: 737-743. (Pubitemid 47267542)
11. Giri S, Jatana M, Rattan R, Won JS, Singh I, Singh AK. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J. 2002; 16: 661-672. (Pubitemid 34465430)
12. Giri S, Khan M, Rattan R, Singh I, Singh AK. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J Lipid Res. 2006; 47: 1478-1492. (Pubitemid 44079902)
13. Giri S, Khan M, Nath N, Singh I, Singh AK. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J Neurochem. 2008; 105: 1820-1833. (Pubitemid 351678503)
14. Hagberg B. Krabbe's disease: clinical presentation of neurological variants. Neuropediatrics. 1984; 15 (Suppl): 11-15.
15. Haq E, Giri S, Singh I, Singh AK. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem. 2003; 86: 1428- 1440.
16. Hittmair K, Wimberger D, Wiesbauer P, Zehetmayer M, Budka H. Early infantile form of Krabbe disease with optic hypertrophy: serial MR examinations and autopsy correlation. Am J Neuroradiol. 1994; 15: 1454-1458. (Pubitemid 24285896)
17. Husain AM, Altuwaijri M, Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology. 2004; 63: 617-620. (Pubitemid 39100814)
18. Kleijer WJ, Keulemans JL, van der Kraan M, Geilen GG, van der Helm RM, Rafi MA et al. Prevalent mutations in the GALC gene of patients with Krabbe disease of Dutch and other European origin. J Inherit Metab Dis. 1997; 20: 587-594. (Pubitemid 27354856)
19. Kobayashi T, Goto I, Yamanaka T, Suzuki Y, Nakano T, Suzuki K. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine. Ann Neurol. 1988; 24: 517-522.
20. Li Y, Brockmann K, Turecek F, Scott CR, Gelb MH. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease. Clin Chem. 2004; 50: 638-640. (Pubitemid 38297317)
21. Lim ZY, Ho AY, Abrahams S, Fensom A, Aldouri M, Pagliuca A et al. Sustained neurological improvement following reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for late-onset Krabbe disease. Bone Marrow Transplant. 2008; 41: 831-832. (Pubitemid 351696349)
22. Lissens W, Arena A, Seneca S, Rafi M, Sorge G, Liebaers I et al. Asingle mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region. Hum Mutat. 2007; 28: 742.
23. Loes DJ, Peters C, KrivitW. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. Am J Neuroradiol. 1999; 20: 316-323. (Pubitemid 30418723)
24. Nagar VA, Ursekar MA, Krishnan P, Jankharia BG. Krabbe disease: unusual MRI findings. Pediatr Radiol. 2006; 36: 61-64. (Pubitemid 43280452)
25. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2001. p. 3421-3452.
26. Ono J, Harada K, Mano T, Sakurai K, Okada S. Differentiation of dys- and demyelination using diffusional anisotropy. Pediatr Neurol. 1997; 16: 63-66. (Pubitemid 27078665)
27. Phelan JA, Lowe LH, Glasier CM. Pediatric neurodegenerative white matter processes: leukodystrophies and beyond. Pediatr Radiol. 2008; 38: 729-749.
28. Prasad VK, Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 2008; 41: 99-108. (Pubitemid 351188906)
29. Raghavan S, Zeng B, Torres PA, Pastores GM, Kolodny EH, Kurtzberg J et al. Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations. J Inherit Metab Dis. 2005; 28: 1005-1009. (Pubitemid 43168937)
30. Saavedra-Matiz C, Orsini J, Morrissey M, Nichols M, Krein L, Isabelle J et al. Newborn screening for Krabbe disease inNewYork State: the first months. In: The 2007 Newborn Screening and Genetic Testing Symposium Abstract Book. Silver Spring: Association of Public Health Laboratories; 2007. p. 41.
31. Sabatelli M, Quaranta L, Madia F, Lippi G, Conte A, Lo Monaco M et al. Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe's disease. Neuromuscul Disord. 2002; 12: 386-391. (Pubitemid 34327214)
32. Sedel F, Tourbah A, Fontaine B, Lubetzki C, Baumann N, Saudubray JM et al. Leukoencephalopathies associ-ated with inborn errors of metabolism in adults. J Inherit Metab Dis. 2008; 31: 295-307.
33. Spiegel R, Bach G, Sury V, Mengistu G, Meidan B, Shalev S et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposinAdeficiency in humans. Mol Genet Metab. 2005; 84: 160-166. (Pubitemid 40164576)
34. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol. 2003; 18: 595-603. (Pubitemid 37258464)
35. Tullu MS, Muranjan MN, Kondurkar PP, Bharucha BA. Krabbe disease: clinical profile. Indian Pediatr. 2000; 37: 939-946.
36. Wang C, Melberg A, Weis J, Mansson JE, Raininko R. The earliestMRimaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease. Acta Neurol Scand. 2007; 116: 268-272. (Pubitemid 47373479)
37. Wenger D, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat. 1997; 10: 268-279. (Pubitemid 27430501)
38. Wenger D, Suzuki K, Suzuki Y, Suzuki K. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: Scriver CR, Beaudet AL, SlyWS, Valle D (eds). The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2001. p. 3669- 3694.
39. Wu YP, McMahon EJ, Matsuda J, Suzuki K, Matsushima GK. Expression of immune-relatedmolecules is down-regulated in twitcher mice following bone marrow transplantation. J Neuropathol Exp Neurol. 2001; 60: 1062-1074. (Pubitemid 33021440)